Global Trust Asset Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.4K | Hold |
455
| – | – | 0.01% | 304 |
|
|
2026
Q1 | $28.6K | Sell |
455
-1
| -0.2% | -$80 | 0.01% | 292 |
|
|
2025
Q4 | $43.5K | Sell |
456
-80
| -15% | -$7.84K | 0.02% | 258 |
|
|
2025
Q3 | $52.3K | Sell |
536
-2,420
| -82% | -$251K | 0.02% | 275 |
|
|
2025
Q2 | $318K | Buy |
2,956
+2,520
| +578% | +$255K | 0.17% | 123 |
|
|
2025
Q1 | $44K | Hold |
436
| – | – | 0.03% | 256 |
|
|
2024
Q4 | $38.9K | Buy |
436
+171
| +65% | +$15.1K | 0.01% | 307 |
|
|
2024
Q3 | $22.2K | Hold |
265
| – | – | 0.01% | 337 |
|
|
2024
Q2 | $20.4K | Hold |
265
| – | – | 0.01% | 317 |
|
|
2024
Q1 | $18.1K | Hold |
265
| – | – | 0.01% | 326 |
|
|
2023
Q4 | $15.3K | Hold |
265
| – | – | 0.01% | 320 |
|
|
2023
Q3 | $14K | Hold |
265
| – | – | 0.01% | 318 |
|
|
2023
Q2 | $14.3K | Hold |
265
| – | – | 0.01% | 316 |
|
|
2023
Q1 | $13.3K | Hold |
265
| – | – | 0.01% | 303 |
|
|
2022
Q4 | $12.3K | Hold |
265
| – | – | 0.01% | 295 |
|
|
2022
Q3 | $10K | Hold |
265
| – | – | 0.01% | 316 |
|
|
2022
Q2 | $10K | Hold |
265
| – | – | ﹤0.01% | 319 |
|
|
2022
Q1 | $12K | Hold |
265
| – | – | 0.01% | 363 |
|
|
2021
Q4 | $11K | Hold |
265
| – | – | ﹤0.01% | 341 |
|
|
2021
Q3 | $11K | Hold |
265
| – | – | ﹤0.01% | 314 |
|
|
2021
Q2 | $11K | Hold |
265
| – | – | 0.01% | 319 |
|
|
2021
Q1 | $10K | Hold |
265
| – | – | 0.01% | 291 |
|
|
2020
Q4 | $10K | Hold |
265
| – | – | 0.01% | 294 |
|
|
2020
Q3 | $10K | Hold |
265
| – | – | 0.01% | 263 |
|
|
2020
Q2 | $9K | Hold |
265
| – | – | 0.01% | 242 |
|
|
2020
Q1 | $8K | Hold |
265
| – | – | 0.01% | 264 |
|
|
2019
Q4 | $12K | Hold |
265
| – | – | 0.01% | 288 |
|
|
2019
Q3 | $11K | Hold |
265
| – | – | 0.01% | 263 |
|
|
2019
Q2 | $11K | Hold |
265
| – | – | 0.01% | 294 |
|
|
2019
Q1 | $10K | Sell |
265
-841
| -76% | -$32.1K | 0.01% | 284 |
|
|
2018
Q4 | $39K | Hold |
1,106
| – | – | 0.03% | 197 |
|
|
2018
Q3 | $43K | Buy |
1,106
+265
| +32% | +$9.26K | 0.03% | 219 |
|
|
2018
Q2 | $28K | Hold |
841
| – | – | 0.02% | 234 |
|
|
2018
Q1 | $23K | Hold |
841
| – | – | 0.02% | 240 |
|
|
2017
Q4 | $21K | Buy |
+841
| New | +$23.2K | 0.01% | 256 |
|
Other funds holding BSX
Global Trust Asset Management's BSX Position: Q2 2026 in Review
Global Trust Asset Management held its Boston Scientific (BSX) position steady in Q2 2026 at 455 shares worth $19.4K. The position accounts for 0.01% of the portfolio, ranked #304.
Global Trust Asset Management first reported a position in BSX in Q4 2017 and has held it in 35 quarters since. The position peaked at $318K in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Global Trust Asset Management held 455 shares of Boston Scientific worth $19.4K as of Q2 2026.
- Global Trust Asset Management left its Boston Scientific share count unchanged in Q2 2026.
- Boston Scientific made up 0.01% of Global Trust Asset Management's portfolio in Q2 2026, its #304 holding.
- Global Trust Asset Management first reported a position in Boston Scientific in Q4 2017 and has held it in 35 quarters since.
- Global Trust Asset Management's Boston Scientific position peaked at $318K in Q2 2025.
- 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Global Trust Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.